美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

三倍做多标普生物-Direxion

231.99

-11.1000-4.57%

盘后：232.200.2100+0.09%17:34 EDT

成交量：29.37万

成交额：6,966.37万

市值：6.20亿

市盈率：- -

高：244.67

开：241.52

低：230.22

收：243.09

52周最高：341.93

52周最低：102.35

股本：267.45万

流通股本：267.45万

量比：0.45

换手率：10.98%

股息：0.90

股息率：0.39%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

圣诺生物(688117.SH)子公司圣诺制药被FDA纳入66-40名单说明

圣诺生物：全资子公司圣诺制药被列入FDA 66-40名单并暂停对美销售

暗流涌动：GRAIL股价因FDA会议文件公布而飙升

医疗保健板块市场综述：市场快讯

医疗保健板块快讯：市场动态一览

健康险“提质”周年考：产品上新与监管纠偏并行，支付端再添推力

CLENE宣布完成400万美元注册直接发行，将资本跑道延长至FDA对CNM-AU8®新药申请做出决定之后。

德国央行：由于能源和医疗保健因素，德国通胀将保持高位。

【纪实】凯莱英化学大分子基地顺利通过美国FDA批准前检查

医疗保健板块动态：市场快讯综述

大摩：对中国医疗健康行业维持吸引的行业观点

大摩：对中国医疗健康行业维持吸引的行业观点

发挥税收激励作用提升居民健康保障能力

美国联邦医疗保险与医疗补助服务中心主任梅赫迈特·奥兹：下周将宣布打击医疗保险欺诈的新举措。

15克卖399元，健乐达的牛初乳贵在哪里？

社保补贴直达个人！按个人缴费25%发放，这类人群抓紧申领

国内首款FDA-GRAS认证巴西甜蛋白实现量产

国内首款FDA-GRAS认证巴西甜蛋白实现量产

南方财经网

规范免责条款、明确特药清单，三大类医疗险示范条款酝酿中

阳光人寿三亚中支被警告，涉委托医护人员代理销售健康保险等

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/LABU/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"三倍做多标普生物-Direxion","latestPrice":231.99,"timestamp":1791835200000,"preClose":243.09,"halted":0,"volume":293716,"hourTrading":{"tag":"盘后","latestPrice":232.2,"preClose":231.99,"latestTime":"17:34 EDT","volume":775,"amount":179617.30925000002,"timestamp":1791840854986,"change":0.21,"changeRate":0.000905,"amplitude":0.006078},"delay":0,"changeRate":-0.04566210045662098,"floatShares":2674486,"shares":2674486,"eps":0,"marketStatus":"盘后交易","change":-11.1,"latestTime":"10-12 17:53:15 EDT","open":241.52,"high":244.6716,"low":230.2215,"amount":69663742.98392001,"amplitude":0.059443,"askPrice":235.5,"askSize":200,"bidPrice":231.65,"bidSize":1,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791849600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":243.09,"sharesOutstanding":3074486,"nav":242.822,"aum":649423578.22,"dividendRate":0.003877,"bidAskSpread":0.002692,"preHourTrading":{"tag":"盘前","latestPrice":242.43,"preClose":243.09,"latestTime":"09:29 EDT","volume":24862,"amount":6085203.2304,"timestamp":1791811795117,"change":-0.66,"changeRate":-0.002715,"amplitude":0.021844},"postHourTrading":{"tag":"盘后","latestPrice":232.2,"preClose":231.99,"latestTime":"17:34 EDT","volume":775,"amount":179617.30925000002,"timestamp":1791840854986,"change":0.21,"changeRate":0.000905,"amplitude":0.006078},"volumeRatio":0.450467,"impliedVol":0.9772,"impliedVolPercentile":0.7331},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2674486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.450467,"shares":2674486,"dividePrice":0.8994,"high":244.6716,"amplitude":0.059443,"preClose":243.09,"low":230.2215,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":231.99,"committee":-0.99005,"eps":0,"divideRate":0.003877,"volume":293716,"delay":0,"ttmEps":0,"open":241.52,"prevYearClose":159.39,"prevWeekClose":243.09,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":257.38,"twentyDayClose":268.39,"sixtyDayClose":265.56},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669133921","title":"圣诺生物(688117.SH)子公司圣诺制药被FDA纳入66-40名单说明","url":"https://stock-news.laohu8.com/highlight/detail?id=2669133921","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669133921?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 12:25","pubTimestamp":1790051123,"startTime":"0","endTime":"0","summary":"智通财经APP讯，圣诺生物 发布公告，公司全资子公司成都圣诺生物制药有限公司于2026年8月20日至2026年8月22日、2026年8月24日及2026年8月27日接受美国食品药品管理局检查组的现场检查。截止目前，经查询FDA官方网站，圣诺制药已于2026年9月19日被列入第 66-40号进口禁令名单;但公司除已收到上述FDA签发的Form FDA 483外，尚未收到美国FDA作出的官方行动指示结论，亦尚未收到 FDA 警告信。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499200.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LABU","01477","BK0239","BK1574","688117","BK4585","BK4588","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669113802","title":"圣诺生物：全资子公司圣诺制药被列入FDA 66-40名单并暂停对美销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2669113802","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669113802?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 12:21","pubTimestamp":1790050889,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134221217","title":"暗流涌动：GRAIL股价因FDA会议文件公布而飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=1134221217","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134221217?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 06:58","pubTimestamp":1790031507,"startTime":"0","endTime":"0","summary":"周一，GRAIL公司股价大幅攀升34%，此轮涨势源于美国食品药品监督管理局在周四顾问委员会会议前夕发布了一系列文件。这些文件将对FDA是否批准该公司研发的多癌种血液检测产品起到决定性作用。自2021年起，GRAIL便以处方形式销售此产品，但FDA至今尚未批准任何一款用于筛查多种癌症的检测手段。然而，该检测对多数癌症病例未能及时发现。无论是上述美国研究，还是在涉及约14.2万人的英国试验中，Galleri仅能捕捉到约三分之一在一年内确诊的癌症病例。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4139","GRAL","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184742504","title":"医疗保健板块市场综述：市场快讯","url":"https://stock-news.laohu8.com/highlight/detail?id=1184742504","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184742504?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 04:53","pubTimestamp":1790024004,"startTime":"0","endTime":"0","summary":"0655 GMT - 瑞银分析师在一份报告中指出，Lundbeck针对癫痫候选药物bexicaserin的研究结果，或有望迅速证明这家丹麦药企多年致力于扭转其研发业务的努力正在初见成效。分析师们表示，研究结果可能凸显该药物成为重磅产品的潜力，并成为Lundbeck从精神病学传统领域转向试验结果更可预测领域战略转变的首个数据点。\"瑞银将Lundbeck股票评级从中性上调至买入，目标价从45丹麦克朗提升至52丹麦克朗。该公司股价上涨2.9%，报43.80丹麦克朗。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","BK4585","LABU","ITM","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127208050","title":"医疗保健板块快讯：市场动态一览","url":"https://stock-news.laohu8.com/highlight/detail?id=1127208050","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127208050?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 00:22","pubTimestamp":1790007770,"startTime":"0","endTime":"0","summary":"0655 GMT——瑞银分析师在报告中指出，丹麦制药商Lundbeck旗下癫痫候选药物bexicaserin的临床研究结果，或将很快印证该公司多年来致力于扭转研发业务的努力已初见成效。分析师们表示，这项研究数据有望凸显该药物成为重磅产品的潜力，同时也会成为Lundbeck从精神病学传统领域转向试验结果更可预测领域的一个关键转折点。基于此判断，瑞银将Lundbeck股票评级从中性上调至买入，目标价亦由45丹麦克朗提升至52丹麦克朗。受此提振，该公司股价上扬2.9%，报43.80丹麦克朗。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4581","BK4585","ITM","XBI","XLV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166405","title":"健康险“提质”周年考：产品上新与监管纠偏并行，支付端再添推力","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166405","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166405?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 20:51","pubTimestamp":1789995060,"startTime":"0","endTime":"0","summary":"9月21日，北京商报记者梳理发现，一年过去，行业在产品服务创新与监管纠偏两条线上同步推进。除了产品在变，监管在收紧，政策推力也在加码。建议监管部门加快出台健康险产品创新发展的具体方案。2026年政府工作报告首次明确提出“加快发展商业健康保险”。2025年12月，首版《商业健康保险创新药品目录》正式发布。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-21/doc-inisqzxv7582232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","XBI","BK4585","BK4588","BK4581","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669569165","title":"CLENE宣布完成400万美元注册直接发行，将资本跑道延长至FDA对CNM-AU8®新药申请做出决定之后。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669569165","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669569165?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 20:31","pubTimestamp":1789993873,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CNM","LU1543694498.USD","LU2413665964.HKD","LU2125910336.SGD","LABU","BK4585","LU1165135440.EUR","LU1620156213.USD","LU2413666004.HKD","LU2229751404.USD","LU2125910179.SGD","IE0009354923.USD","BK4539","LU1596574779.USD","LU1721427968.SGD","BK4588","BK4104","LU1620156130.USD","LU1923621640.USD","LU2089279066.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669715298","title":"德国央行：由于能源和医疗保健因素，德国通胀将保持高位。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669715298","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669715298?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 18:03","pubTimestamp":1789985000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","NOBL","BK4585","BK4581","BK4550","XLV","CGVV","FLGR","LABU","BK4588","FGM","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669151594","title":"【纪实】凯莱英化学大分子基地顺利通过美国FDA批准前检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2669151594","media":"同花顺","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669151594?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 17:05","pubTimestamp":1789981500,"startTime":"0","endTime":"0","summary":"凯莱英化学大分子基地生产的某原料药项目，于2026年6月底至7月初完成了美国食品药品监督管理局(FDA)的批准前检查(PAI)，并于8月底收到FDA签发的工厂检查报告(EIR)，标志着公司合规能力再次 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260921/c680129684.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260921/c680129684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0239","BK4585","002821","BK1191","BK4588","BK0132","LU1328615791.USD","LABU","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196076014","title":"医疗保健板块动态：市场快讯综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1196076014","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196076014?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 16:25","pubTimestamp":1789979119,"startTime":"0","endTime":"0","summary":"0444 GMT - 海天国际在首席执行官增持公司股份后，呈现出颇具吸引力的入场点位，花旗分析师Eric Lau在一份报告中指出。该分析师表示，此次增持的时机也印证了公司下半年盈利复苏的预期。花旗预计，这家塑料注塑机制造商的国内销售将推动其下半年业绩，从而抵消海外销售的疲软态势。该投行预计下半年营收与净利润将分别同比增长2.3%和5.0%。花旗维持其买入评级，目标价定为27港元，理由是估值并不高昂。股价目前上涨3.6%，报17.69港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4581","ITM","BK4585","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669588361","title":"大摩：对中国医疗健康行业维持吸引的行业观点","url":"https://stock-news.laohu8.com/highlight/detail?id=2669588361","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669588361?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 14:25","pubTimestamp":1789971900,"startTime":"0","endTime":"0","summary":"9月21日消息，摩根士丹利(MS.US)发表研报指，《医药工业发展“十五五”规划》提到，目标中国创新药行业在2030年复合年增长逾20%，相当于行业规模扩大至现时约2.5倍。规划亦明确支持中国生物 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260921/c680119444.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260921/c680119444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU0053666078.USD","LU0320765646.SGD","LU1989772923.USD","LU2028103732.USD","LU0528227936.USD","LU1668664300.SGD","LU2089283258.USD","IXJ","KBWB","LU0314104364.USD","LU1244550494.USD","BK4504","LU0098860793.USD","LU1732799900.SGD","LU0912757837.SGD","LU0225283273.USD","LU0267386448.USD","LU1791710582.SGD","LU2357305700.SGD","VHT","IAI","LABU","LU1363072403.SGD","BK4581","LU1162221912.USD","LU1244550577.SGD","XLV","LU0390134368.USD","LU1720051108.HKD","LU0971096721.USD","LU2089284900.SGD","LU1720051017.SGD","LU2264538146.SGD","BK4585","BK4588","LU1988902786.USD","LU0006306889.USD","IE00BKVL7J92.USD","BK4534","IE00B775SV38.USD","IE00BZ1G4Q59.USD","LU0882574139.USD","LU0210528500.USD","XBI","159760","LU0795875086.SGD","LU2133065610.SGD","IE00B3S45H60.SGD","LU0234570918.USD","LU1791710400.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669301461","title":"大摩：对中国医疗健康行业维持吸引的行业观点","url":"https://stock-news.laohu8.com/highlight/detail?id=2669301461","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669301461?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 14:16","pubTimestamp":1789971397,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2357305700.SGD","LU0267386448.USD","LU0320765646.SGD","LU1244550494.USD","LU2089283258.USD","LU1791710582.SGD","LU0528227936.USD","LU1548497426.USD","LU1720051108.HKD","LU0882574139.USD","LU0557290698.USD","LU1732800096.USD","IXJ","XLV","LU0106261372.USD","LU0795875086.SGD","LU1732799900.SGD","LABU","LU1363072403.SGD","LU0912757837.SGD","LU1720051017.SGD","BK4588","LU2089284900.SGD","BK4581","LU0098860793.USD","VHT","LU0390134368.USD","LU0210528500.USD","LU2133065610.SGD","LU2028103732.USD","KBWB","BK4534","LU1244550577.SGD","IE00B3S45H60.SGD","LU0158827781.USD","LU2271345857.HKD","LU0971096721.USD","LU1668664300.SGD","XBI","159760","LU2347655156.SGD","IE00BZ1G4Q59.USD","BK4550","IE00BKVL7J92.USD","LU1989772923.USD","LU1989772840.SGD","IAI","BK4504","LU0795875169.SGD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669818728","title":"发挥税收激励作用 提升居民健康保障能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2669818728","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669818728?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 04:03","pubTimestamp":1789934580,"startTime":"0","endTime":"0","summary":"□ 张旋健全多层次医疗保障体系，是增进民生福祉、提高人民生活品质的重要内容。随着居民收入水平持续提高和人口结构变化，群众的健康保障需求日益多样化，仅靠基本医疗保险难以完全覆盖不 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260921/c680099086.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260921/c680099086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK4588","BK4585","BK4581","XLV","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668905879","title":"美国联邦医疗保险与医疗补助服务中心主任梅赫迈特·奥兹：下周将宣布打击医疗保险欺诈的新举措。","url":"https://stock-news.laohu8.com/highlight/detail?id=2668905879","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668905879?lang=zh_cn&edition=fundamental","pubTime":"2026-09-19 21:46","pubTimestamp":1789825602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4533","LU1093756325.SGD","BK4566","LU0208291251.USD","LU0348723411.USD","BK4581","LU0256863811.USD","LU0170899867.USD","LU0070302665.USD","LU1983260115.SGD","LU0417517546.SGD","BK4585","LU0266013472.USD","SG9999014021.USD","SG9999014013.SGD","IHF","FXH","LU0211331839.USD","RSPH","LU0390134368.USD","XLV","XHS","LU0238689110.USD","LU1093756168.USD","XBI","BK4588","SG9999014005.SGD","BK4154","HUM","LU0320765489.SGD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668977516","title":"15克卖399元，健乐达的牛初乳贵在哪里？","url":"https://stock-news.laohu8.com/highlight/detail?id=2668977516","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668977516?lang=zh_cn&edition=fundamental","pubTime":"2026-09-19 14:12","pubTimestamp":1789798351,"startTime":"0","endTime":"0","summary":"如今，百纳福将一盒15克的诺珍牌牛初乳粉卖到399元，按照标示用量连续食用，每月需要购买两盒，花费798元。公开市场上，IgG含量接近健乐达的30%牛初乳粉，每公斤报价为420元至650元。按照这一价格计算，15克原料价值约为6.3元至9.75元，仅相当于健乐达售价的1.6%至2.4%；399元的成品价达到公开原料价格的41倍至63倍。2015年前后，健乐达被确立为核心品牌，牛初乳粉为主打产品。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789121924759330792","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668977547","title":"社保补贴直达个人！按个人缴费25%发放，这类人群抓紧申领","url":"https://stock-news.laohu8.com/highlight/detail?id=2668977547","media":"微大庆","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668977547?lang=zh_cn&edition=fundamental","pubTime":"2026-09-19 14:02","pubTimestamp":1789797720,"startTime":"0","endTime":"0","summary":"延续实施扩大社会保险补贴范围政策至2026年底，直接补给个人，最长可领12个月！按照基本养老保险费、基本医疗保险费、失业保险费个人实际缴纳额的25%给予补贴。补贴通过“先缴后补”的方式按月发放，申领期限截至2026年底，每人累计享受补贴期限不超过12个月。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-19/doc-inisiwwa9842638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","XLV","BK4588","BK4581","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668602069","title":"国内首款FDA-GRAS认证巴西甜蛋白实现量产","url":"https://stock-news.laohu8.com/highlight/detail?id=2668602069","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668602069?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 21:36","pubTimestamp":1789652184,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668988649","title":"国内首款FDA-GRAS认证巴西甜蛋白实现量产","url":"https://stock-news.laohu8.com/highlight/detail?id=2668988649","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668988649?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 21:34","pubTimestamp":1789652040,"startTime":"0","endTime":"0","summary":"金斯瑞生物科技股份有限公司（HK.1548）今日对外宣布，旗下子公司百斯杰生物位于中国济南的甜蛋白自动化智能产线竣工。这标志着全球首条专为甜蛋白设计的商业化生产线正式落成，也表明百斯杰在原有甜蛋白产品工业化生产能力的基础上完成战略跃升，率先实现了全产业链贯通，成为全球合成生物甜蛋白领域唯一拥有自主专线量产能力的行业领跑者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609173877578131.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609173877578131.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","LABU","159100","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668967812","title":"规范免责条款、明确特药清单，三大类医疗险示范条款酝酿中","url":"https://stock-news.laohu8.com/highlight/detail?id=2668967812","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668967812?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 20:36","pubTimestamp":1789648560,"startTime":"0","endTime":"0","summary":"消费者在投保过程中容易忽视免责条款进而引发纠纷乃至投诉。此外，在特定药品费用保障方面，示范条款将明确保险公司约定的特定药品清单，需涵盖保险业协会发布的商业健康保险药品保障清单，为药品保障清单落地实施和动态调整预留衔接空间，进一步满足人民群众看病用药需求，促进保险、医疗、医药产业协同，支持生物医药新兴产业高质量发展。而免责条款的制定，则为了规范保险业务活动、维护保险活动当事人合法权益。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-17/doc-iniscvfx3662502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XLV","BK4588","BK4585","XBI","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961009","title":"阳光人寿三亚中支被警告，涉委托医护人员代理销售健康保险等","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961009","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961009?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 19:47","pubTimestamp":1789645621,"startTime":"0","endTime":"0","summary":"蓝鲸新闻9月17日讯，近日，国家金融监督管理总局三亚监管分局发布行政处罚决定书，剑指阳光人寿保险股份有限公司三亚中心支公司。罚单显示，阳光人寿保险股份有限公司三亚中心支公司的主要违法违规行为是：委托医护人员代理销售健康保险、从业人员在银行营业场所从事保险销售相关活动。针对上述违法行为，国家金融监督管理总局三亚监管分局对阳光人寿保险股份有限公司三亚中心支公司补充警告。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789638772464792162","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["XBI","BK4585","BK4581","XLV","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}